Evaluation and Treatment of Gross Ascites

Initial Diagnostic Evaluation

• The American Association for the Study of Liver Diseases recommends that all patients with gross ascites require diagnostic paracentesis before initiating treatment, even without signs of infection 1, 2
• The European Association for the Study of the Liver suggests performing paracentesis 15 cm lateral to the umbilicus in the lower quadrants, avoiding the epigastric vessels 3
• Coagulopathy or thrombocytopenia should not be a reason to withhold paracentesis, as serious complications occur in less than 1 in 1000 procedures 3
• Inoculate at least 10 mL of ascitic fluid into aerobic and anaerobic blood culture bottles at bedside before any antibiotics 1
• Send fluid for neutrophil count, total protein, albumin, and simultaneous serum albumin to exclude spontaneous bacterial peritonitis 2, 4

Critical Diagnostic Calculations

• Calculate serum-ascites albumin gradient (SAAG) by subtracting ascitic fluid albumin from serum albumin to confirm cirrhotic ascites 2
• A SAAG ≥1.1 g/dL indicates portal hypertension with 97% accuracy 5
• Neutrophil count >250 cells/mm³ diagnoses spontaneous bacterial peritonitis requiring immediate antibiotics 1, 2

Immediate Therapeutic Management

• The American Association for the Study of Liver Diseases recommends therapeutic paracentesis as the first-line treatment for gross ascites, removing all accessible fluid in a single session 4
• Administer albumin at 8 g per liter of ascites removed when removing >5 liters to prevent post-paracentesis circulatory dysfunction 4, 6
• Restrict dietary sodium to 2 g/day starting immediately, and provide formal dietician consultation to maximize adherence while preventing malnutrition 4, 6
• Fluid restriction is not indicated unless serum sodium <125 mmol/L 4, 6

Diuretic Therapy

• Start combination therapy with spironolactone 100 mg daily plus furosemide 40 mg daily, as patients with long-standing gross ascites respond better to combined treatment than monotherapy 4
• Never use furosemide as monotherapy, as it is less effective than spironolactone in portal hypertension 6
• Increase spironolactone stepwise up to 400 mg/day, waiting at least 72 hours between increases due to long half-life 4

Critical Monitoring and Safety

• Monitor serum potassium within 1 week of initiation or dose changes, then regularly 4
• Check serum creatinine, electrolytes, and renal function frequently during diuresis 4
• If creatinine rises significantly or exceeds 150 μmol/L, stop diuretics immediately 6
• For serum sodium <120 mmol/L, stop diuretics and consider volume expansion with albumin 6

Refractory Ascites Management

• Ascites is refractory when it cannot be mobilized or recurs early despite sodium restriction and maximum diuretics (spironolactone 400 mg/day plus furosemide 160 mg/day) 4
• Refer all patients with ascites for liver transplantation evaluation, as ascites development reduces 5-year survival from 80% to 30% 5

Key Pitfalls to Avoid

• Never assume alcoholic patients have alcoholic liver disease—always investigate other causes 3
• Do not restrict fluids unless hyponatremia is present 4, 6
• Avoid NSAIDs, which reduce diuretic efficacy and worsen renal function 3
• Do not give fresh frozen plasma before paracentesis—it is not supported by evidence 3

Evidence‑Based Management of Ascitic Fluid Cultures and Spontaneous Bacterial Peritonitis

Diagnostic Fluid Collection

• Collect ≥10 mL of ascitic fluid into both aerobic and anaerobic blood‑culture bottles at the bedside before any antibiotics are given; this approach achieves >90 % culture sensitivity (American Association for the Study of Liver Diseases – AASLD, strong evidence) 7, 8
• Obtain simultaneous peripheral blood cultures to increase the probability of isolating the causative organism (AASLD) 7, 8

Diagnosis of Spontaneous Bacterial Peritonitis (SBP)

• A neutrophil (PMN) count >250 cells/mm³ in ascitic fluid defines SBP and requires immediate empiric antimicrobial therapy (AASLD) 7, 8

Empiric Antimicrobial Therapy

• Start intravenous empiric antibiotics promptly, without waiting for culture results, when SBP is diagnosed (AASLD) 7, 8
• When multidrug‑resistant organisms are uncommon, use IV cefotaxime 2 g every 12 h as first‑line treatment for SBP (AASLD) 7, 8
• In nosocomial infections, recent hospitalizations, or critically ill ICU patients, begin carbapenem therapy; inappropriate initial therapy in septic shock increases mortality tenfold (AASLD) 7, 8

Antimicrobial Stewardship

• Narrow or de‑escalate antibiotic coverage as soon as culture and susceptibility results are available (AASLD) 7, 8

Guideline for Evaluation and Management of Ascites

Diagnostic Evaluation

• Perform immediate diagnostic paracentesis in all patients with new‑onset grade 2 (moderate) or grade 3 (large/tense) ascites before initiating any therapy. 9
• Indications for diagnostic paracentesis include: new‑onset grade 2 or 3 ascites, hospitalization for worsening ascites, and any acute decompensation such as fever, abdominal pain, encephalopathy, gastrointestinal bleeding, hypotension, or renal insufficiency. [10][9]
• Obtain ≥10 mL of ascitic fluid and inoculate it into both aerobic and anaerobic blood‑culture bottles at the bedside before starting antibiotics. 9

Baseline Laboratory and Imaging

• Order liver function tests, renal function tests, and serum and urine electrolytes as part of the initial work‑up. [10][9]
• Perform an abdominal Doppler ultrasound to confirm the presence of ascites and to assess for portal‑vein thrombosis or other vascular abnormalities. [9][11]

Ascitic Fluid Analysis

First Episode (in‑ and out‑patients)

• Measure the neutrophil (PMN) count; a value > 250 cells/mm³ diagnoses spontaneous bacterial peritonitis (SBP) and mandates immediate empiric antibiotics. [10][9]
• Calculate the serum‑ascites albumin gradient (SAAG) by subtracting ascitic fluid albumin from the simultaneously obtained serum albumin. [9][12]
• Determine total protein concentration of the ascitic fluid. [9][12]
• Send cultures by bedside inoculation of fluid into blood‑culture bottles. [10][9]

Recurrent Ascites (in‑patients)

• Repeat PMN count and culture as above. 9
• Measure protein concentration only when primary SBP prophylaxis is being considered. [9][12]
• SAAG calculation is not required for recurrent ascites. [9][12]

Interpretation of SAAG

• SAAG ≥ 1.1 g/dL indicates portal hypertension with ≈ 97 % accuracy (e.g., cirrhosis, cardiac failure, massive liver metastases). [9][12]
• SAAG < 1.1 g/dL effectively excludes portal hypertension and suggests alternative etiologies such as peritoneal carcinomatosis, tuberculosis, or pancreatic disease. [9][12]

Ascites Grading

• Grade 1 (mild): Detectable only by ultrasound; no specific treatment required. 9
• Grade 2 (moderate): Symmetrical abdominal distension with positive shifting dullness. 9
• Grade 3 (large/tense): Marked abdominal distension. 9

First‑Line Therapeutic Strategies

Large‑Volume Paracentesis

• The peritoneal membrane reabsorbs ≈ 500 mL/day; therefore, large‑volume paracentesis is more effective than diuretics alone for massive ascites. 9

Sodium Restriction

• Initiate dietary sodium restriction to < 2 g/day (≈ 88 mmol) immediately after diagnosis. 9
• Fluid restriction is not indicated unless serum sodium falls < 125 mEq/L. [9][13]

Diuretic Therapy

• Start combination therapy with spironolactone 100 mg daily + furosemide 40 mg daily. (Society recommendation not specified.)
• Titrate spironolactone stepwise up to a maximum of 400 mg/day, waiting ≥ 72 hours between dose increases because of its long half‑life. [9][13]
• Increase furosemide as needed up to a maximum of 160 mg/day. 9
• Maintain the 100 : 40 mg spironolactone‑to‑furosemide ratio during dose escalation. 9

Weight‑Loss Targets

• Aim for a weight loss of ≈ 0.5 kg/day in patients without peripheral edema. [9][12]
• Aim for a weight loss of up to 1 kg/day in patients with peripheral edema. [9][12]
• Exceeding these rates increases the risk of plasma‑volume contraction, renal failure, and hyponatremia. [9][12]

Monitoring During Diuretic Therapy

• Assess 24‑hour urinary sodium excretion or a spot urine Na/K ratio to guide diuretic effectiveness. [9][12]
• A spot urine Na/K ratio > 1 indicates that the patient is excreting more sodium than potassium, reflecting an adequate diuretic response. 12
• Discontinue diuretics for severe hyper‑kalemia or symptomatic hyponatremia. 9

Prognosis and Transplant Considerations

• Development of ascites reduces five‑year survival from ≈ 80 % (compensated cirrhosis) to ≈ 30 % (decompensated cirrhosis). 10
• One‑year and two‑year mortality after ascites onset are approximately 40 % and 50 %, respectively. 10
• All patients with ascites should be evaluated for liver transplantation eligibility. 10

Key Pitfalls to Avoid

• Do not assume cirrhosis as the cause of ascites; always calculate SAAG to exclude malignancy, tuberculosis, or cardiac failure. 9
• Do not impose fluid restriction unless serum sodium is < 125 mEq/L, as unnecessary restriction worsens quality of life without benefit. [9][13]

Management of Ascites in Cirrhosis

Prognostic Significance

Pathophysiologic Indicators

Initial Diagnostic Evaluation

Mandatory Paracentesis

Fluid Analysis

Baseline Laboratory & Imaging

First‑Line Management

Sodium Restriction

Diuretic Therapy

Target Weight Loss

Therapeutic Paracentesis for Tense Ascites

Monitoring During Treatment

Management of Refractory Ascites

Definition

Treatment Options

Transplant Referral

Critical Pitfalls

Management of Hemorrhagic Ascites in Cirrhosis (Evidence‑Based Recommendations)

Immediate Diagnostic Evaluation

• Diagnostic paracentesis should be performed without delay in every patient with hemorrhagic ascites, irrespective of coagulation status or platelet count. – AASLD guideline (based on Hepatology 2004 and 2021 data) [18][19]
• Coagulopathy only contraindicates paracentesis when overt fibrinolysis or disseminated intravascular coagulation is present; such events occur in < 1 per 1,000 procedures. – AASLD (expert consensus) 18
• No specific INR or platelet threshold mandates postponement of paracentesis; the procedure is safe across a wide range of values. – AASLD (clinical evidence) [18][19]
• Prophylactic transfusion of fresh‑frozen plasma or platelets before paracentesis is not recommended. – AASLD (level C recommendation) [18][19]

Ascitic Fluid Collection and Laboratory Analysis

• Obtain ≥ 10 mL of ascitic fluid and inoculate bedside into aerobic and anaerobic blood‑culture bottles before any antibiotics are started. – AASLD (clinical practice) 19
• Measure neutrophil (PMN) count; a value > 250 cells/mm³ defines spontaneous bacterial peritonitis (SBP) and mandates immediate antibiotic therapy. – AASLD (strong recommendation) [19][20]
• Send total protein and albumin together with a simultaneous serum albumin to calculate the serum‑ascites albumin gradient (SAAG). – AASLD (standard diagnostic work‑up) [18][19]20
• Perform bacterial cultures using the bedside blood‑culture bottles to improve pathogen detection. – AASLD (evidence‑based) 19

Serum‑Ascites Albumin Gradient (SAAG) Interpretation

• SAAG ≥ 1.1 g/dL indicates portal hypertension with 97 % diagnostic accuracy, confirming cirrhotic ascites as the underlying mechanism. – AASLD (high‑quality evidence) [18][20]
• SAAG < 1.1 g/dL suggests non‑portal‑hypertensive etiologies such as peritoneal carcinomatosis, tuberculous peritonitis, or pancreatic disease. – AASLD (clinical guidance) [18][20]

Evaluation for Underlying Malignancy

• Obtain α‑fetoprotein (AFP) level and abdominal imaging (ultrasound, CT, or MRI) to exclude hepatocellular carcinoma (HCC), the most common malignant cause of hemorrhagic ascites in cirrhosis. – AASLD (screening recommendation) 20

Therapeutic Paracentesis and Albumin Replacement

• For tense or symptomatic hemorrhagic ascites, perform a single‑session large‑volume paracentesis removing all accessible fluid. – AASLD (level B) 19
• If > 5 L of fluid is removed, administer albumin 8 g per liter of ascites withdrawn to prevent post‑paracentesis circulatory dysfunction. – AASLD (strong recommendation) 19

Sodium Restriction and Diuretic Therapy

• Initiate dietary sodium restriction to < 2 g/day (≈ 88 mmol/day) immediately upon diagnosis. – AASLD (standard of care) [19][20]
• Start combination diuretics: spironolactone 100 mg daily plus furosemide 40 mg daily, titrated as needed. – AASLD (evidence‑based regimen) 19
• Fluid restriction is not indicated unless serum sodium falls below 125 mmol/L. – AASLD (clinical guideline) 19

Infection Management

• If PMN count exceeds 250 cells/mm³, begin empiric intravenous cefotaxime 2 g every 12 hours promptly. – AASLD (strong recommendation) 19
• Maintain a low threshold for repeat paracentesis in patients who develop fever, abdominal pain, or encephalopathy, given the markedly higher SBP rate in hemorrhagic ascites. – AASLD (clinical vigilance) [19][20]

Liver Transplantation Referral and Palliative Care

• All patients with hemorrhagic ascites should be referred urgently for liver transplantation evaluation, as this finding denotes advanced decompensated cirrhosis with a 5‑year survival of only ~30 %. – AASLD (high‑priority referral) 20
• The development of any ascites (hemorrhagic or non‑hemorrhagic) constitutes an indication for transplant evaluation. – AASLD (listing criteria) 20
• Patients deemed unsuitable for transplantation should receive a palliative‑care consultation. – AASLD (holistic care) 19

Safety Pitfalls to Avoid

• Do not withhold paracentesis because of coagulopathy; serious bleeding complications are exceedingly rare (< 0.1 %). – AASLD (safety statement) [18][19]
• Do not give prophylactic fresh‑frozen plasma or platelets before paracentesis; no evidence supports benefit and it delays diagnosis. – AASLD (level C) [18][19]
• Do not impose fluid restriction unless serum sodium is < 125 mmol/L; unnecessary restriction worsens quality of life without clinical gain. – AASLD (level C) 19